Literature DB >> 18838974

Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection?

Colm A O'Morain1, J P Anthony O'Connor.   

Abstract

Entities:  

Year:  2008        PMID： 18838974     DOI： 10.1038/ncpgasthep1276

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  7 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.

Authors:  M Lee; J A Kemp; A Canning; C Egan; G Tataronis; F A Farraye
Journal:  Arch Intern Med       Date:  1999-10-25

3.  Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005).

Authors:  S A Chisholm; E L Teare; K Davies; R J Owen
Journal:  Euro Surveill       Date:  2007-07-01

Review 4.  New concepts of resistance in the treatment of Helicobacter pylori infections.

Authors:  David Y Graham; Akiko Shiotani
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-04-29

5.  Seven-day therapy for Helicobacter pylori in the United States.

Authors:  N Vakil; F Lanza; H Schwartz; J Barth
Journal:  Aliment Pharmacol Ther       Date:  2004-07-01       Impact factor: 8.171

6.  Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.

Authors:  Nadim S Jafri; Carlton A Hornung; Colin W Howden
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

7.  Factors influencing the eradication of Helicobacter pylori with triple therapy.

Authors:  D Y Graham; G M Lew; H M Malaty; D G Evans; D J Evans; P D Klein; L C Alpert; R M Genta
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682
  7 in total
  2 in total

1.  Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

Authors:  Javier P Gisbert; Xavier Calvet
Journal:  Clin Exp Gastroenterol       Date:  2012-03-13

2.  Helicobacter  pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.

Authors:  Sotirios D Georgopoulos; Vasilios Papastergiou; Stylianos Karatapanis
Journal:  Gastroenterol Res Pract       Date:  2012-06-19       Impact factor: 2.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.